GNPX
Genprex, Inc.
Key Financials
Revenue
$0
NaN%
Net Income
$-16228953
↑ 23.1%
Total Liabilities
$2.2M
↓ 12.3%
Operating Income
$-15515619
↑ 26.7%
Total Assets
$10.2M
↑ 146.3%
Cash & Equivalents
$7.8M
↑ 388.9%
Operating Cash Flow
$-15311209.00
↑ 10.7%
Shareholders' Equity
$8.0M
↑ 391.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/18/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| 8-K | 8/3/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K | 7/14/2026 | View on SEC |
| S-8 | 6/26/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GNPX |
| Company Name | Genprex, Inc. |
| CIK | 1595248 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | TX |
| Phone | 512-537-7997 |